MIGRA-FREE Trial

Study Overview

A completed pivotal trial that studied a CGRP inhibitor for prevention of chronic migraine. Results showed significant reduction in monthly migraine days with good tolerability.

Inclusion Criteria

• ✓Adults aged 18-65 years
• ✓≥15 headache days per month
• ✓≥8 migraine days per month
• ✓History of migraine for at least 1 year

Exclusion Criteria

• ✗Medication overuse headache
• ✗Prior CGRP inhibitor use
• ✗Cardiovascular disease
• ✗Current opioid use for migraine